Background/Aims: To monitor possible changes in the cumulated drusen or geographic atrophy area size (CDGAS) of nonexudative age-related macular degeneration (AMD) in patients before and after cataract surgery, using a new tool for computer-aided image quantification. Methods: Randomized, prospective, clinical trial. 54 patients with cataract and nonexudative AMD were randomly assigned into an early surgery group (ES = 28) and a control group (CO = 26) with a 6-month delay of surgery. CDGAS was determined with the MD3RI tool for contour drawing in a central region of digitized fundus photographs, measuring 3,000 µm in diameter. To evaluate CDGAS progression, differences in pixels and square millimeters were calculated by equivalent tests. Results: Forty-nine patients completed the visits over the 12-month period (ES = 27 and CO = 22). Mean pixel values increased from 201.5 (11.33 × 10–3 mm2) to 202.7 (11.39 × 10–3 mm2) in the ES group and from 191.6 (10.77 × 10–3 mm2) to 194.6 (10.94 × 10–3 mm2) in the CO group. Finally, equivalence of CDGAS differences between ES and CO could be demonstrated. No exudative AMD was recorded during the study period. Conclusion: In our cohorts, no significant changes were found in CDGAS 12 months after cataract surgery. The MD3RI software could serve as an efficient, precise and objective tool for AMD quantification and monitoring in future trials.

1.
Foran S, Wang JJ, Mitchell P: Causes of visual impairment in two older population cross-sections: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2003;10:215–225.
2.
Klein R, Klein BE, Linton KL: Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933–943.
3.
Holz FG, Bindewald-Wittich A, Fleckenstein M, Dreyhaupt J, Scholl HP, Schmitz-Valckenberg S, FAM Study Group: Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol 2007;143:463–472.
4.
Busbee BG, Brown MM, Brown GC, Sharma S: Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 2002;109:606–612.
5.
Leinonen J, Laatikainen L: Changes in visual acuity of patients undergoing cataract surgery during the last two decades. Acta Ophthalmol Scand 2002;80:506–511.
6.
Phillips KA, Cockrum PC, Kennedy RH: Worldwide blindness and prevention guidelines for frontline practitioners. Today’s Ther Trends 2003;21:71–83.
7.
Klein R, Wang Q, Klein BE, Moss SE, Meuer SM: The relationship of age-related maculopathy, cataract and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182–191.
8.
Klein R, Klein BE, Wang Q, Moss SE: Is age-related maculopathy associated with cataracts? Arch Ophthalmol 1994;112:191–196.
9.
Liu IY, White L, LaCroix AZ: The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health 1989;79;765–769.
10.
Age-Related Eye Disease Research Group: Risk factors associated with age-related macular degeneration. A case-control study in the AREDS. Ophthalmology 2000;107:2224–2232.
11.
Wang JJ, Mitchell PG, Cumming RG, Lim R: Cataract and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol 1999;6:317–326.
12.
Hammond BR Jr, Wooten BR, Snodderly DM: Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vision Res 1996;18:3003–3009.
13.
Cruickshanks KJ, Klein R, Klein BE, Nondahl DM: Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2001;119:246–250.
14.
Falcone PM: Vitreomacular traction syndrome confused with pseudophakic cystoid macular edema. Ophthalmic Surg Lasers 1996;27:392–394.
15.
Vinores SA, Amin A, Derevjanik NL: Immunohistochemical localisation of blood-retinal barrier and breakdown sites associated with post-surgical macular edema. Histochem J 1994;26:655–665.
16.
Armbrecht AM, Findlay C, Kaushal S, Aspinall P, Hill AR, Dhillon B: Is cataract surgery justified in patients with age-related macular degeneration? A visual function and quality of life assessment. Br J Ophthalmol 2000;84:1343–1348.
17.
Pollack A, Markovich A, Bukelman A, Oliver M: Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology 1996;103:1546–1554.
18.
Stolba U, Binder S, Velikay M: Does cataract surgery with lens implantation influence the course of age-related macular degeneration? J Fr Ophthalmol 1989;12:897–901.
19.
Armbrecht AM, Findlay C, Aspinall PA, Hill AR, Dhillon B: Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J Cataract Refract Surg 2003;29:686–693.
20.
Pollack A, Bukelman A, Zalish M, Leiba H, Oliver M: The course of age-related macular degeneration following bilateral cataract surgery. Ophthalmic Surg Lasers 1998;29:286–294.
21.
Lamoureux EL, Hooper CY, Lim L, Pallant JF, Hunt N, Keeffe JE, Guymer RH: Impact of cataract surgery on quality of life in patients with early age-related macular degeneration. Optom Vis Sci 2007;84:683–688.
22.
Menghini M, Sutter FK, Barthelmes D, Fleischhauer JC, Kurz-Levin MM, Boesch MM, Helbig H: Does cataract surgery increase the risk of exudative age-related macular degeneration? Results from a large retrospective case-control study (in German). Klin Monbl Augenheilkd 2007;224:288–291.
23.
Shuttleworth GN, Luhishi EA, Harrad RA: Do patients with age-related maculopathy and cataract benefit from cataract surgery? Br J Ophthalmol 1998;82:611–616.
24.
Van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, Pameyer JH, de Jong PT: Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol 1994;78:441–445.
25.
Klein R, Klein BE, Jensen SC, Cruickshanks KJ: The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 1998;116:506–513.
26.
Klein R, Klein BE, Wong TY, Tomany SC, Cruickshanks KJ: The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2002;120:1551–1558.
27.
Wang JJ, Klein R, Smith W, Klein BE, Tomany S, Mitchell P: Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. Ophthalmology 2003;110:1960–1967.
28.
Sutter FK, Menghini M, Barthelmes D, Fleischhauer JC, Kurz-Levin MM, Bosch MM, Helbig H: Is pseudophakia a risk factor for neovascular age-related macular degeneration? Invest Ophthalmol Vis Sci 2007;48:1472–1475.
29.
Cugati S, Mitchell P, Rochtchina E, Tan AG, Smith W, Wang JJ: Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 2006;113:2020–2025.
30.
Buch H, Vinding T, la Cour M, et al: Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmol Scand 2005;83:409–418.
31.
Freeman EE, Munoz B, West SK, Tielsch JM, Schein OD: Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol 2003;135:849–856.
32.
Pham TQ, Cugati S, Rochtchina E, Mitchell P, Maloof A, Wang JJ: Age-related maculopathy and cataract surgery outcomes: visual acuity and health-related quality of life. Eye 2007;21:324–330.
33.
Kaiserman I, Kaiserman N, Elhayany A, Vinker S: Cataract surgery is associated with a higher rate of photodynamic therapy for age-related macular degeneration. Ophthalmology 2007;114:278–282.
34.
World Medical Association Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. Helsinki, Finland, 1964, amended in Tokyo, Japan, 1975; Venice, Italy, 1983; Hong Kong 1989; Somerset West, South Africa, 1996; Edinburgh, Scotland, 2000; Washington, USA, 2002; Tokyo, Japan 2004. http://www.wma.net/e/policy/b3.htm (accessed 15 Jan, 2008).
35.
ICH Harmonised Tripartite Guideline for Good Clinical Practice, 1996. http://www.fda.gov/oc/gcp/guidance.html (accessed 15 Jan, 2008).
36.
Directive 2001/20/EC of the European Parliament and of the Council of 4 April, 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use (2001). Official Journal of the European Communities L/21/34 1.5.2001 and the EudraCT Supporting Documentation updated 04/08/05. http://eudract.emea.eu.int/document.html (accessed 15 Jan, 2008).
37.
Chylack LT, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY: The Lens Opacities Classification System III. Arch Ophthalmol 1993;111:831–836.
38.
Radner W, Willinger U, Obermayer W, Mudrich C, Velikay-Parel M, Eisenwort B: A new reading chart for simultaneous determination of reading vision and reading speed. Klin Monatsbl Augenheilkd 1998;213:174–181.
39.
Linder M, Chang TS, Scott IU, Hay D, Chambers K, Sibley LM, Weis E: Validity of the Visual Function Index (VF-14) in patients with retinal disease. Arch Ophthalmol 1999;117:1611–1616.
40.
Mora A, Fonseca J, Vieira P: Variability and repeatability tests of ARMD assessment using the AD3RI tool; in Camarinha-Matos L, Shahamatnia E, Nunes G (eds): Technological Innovation for Value Creation. Boston, Springer, 2012, vol 372, pp 583–590.
41.
Mora A, Fonseca J, Vieira P: MD3RI a tool for computer-aided drusen contour drawing. Proceedings of Biomed-2006, Innsbruck, Austria, 15–17 February, 2006. http://www.uninova.pt/~drusens/.
42.
Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R: An international classification system for age-related maculopathy and age-related macular degeneration. The international ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367–374.
43.
Scholl H, Peto T, Dandekar S, Bunce C, Xing W, Jenkins S, Bird A: Inter- and intra-observer variability in grading lesions of age-related maculopathy and macular degeneration. Graefes Arch Clin Exp Ophthalmol 2003;241:39–47.
44.
Knudtson MD, Klein R, Klein BE, Lee KE, Meuer SM, Tomany SC: Location of lesions associated with age-related maculopathy over a 10-year period: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 2004;45:2135–2142.
45.
Kirkpatrick JN, Spencer T, Manivannan A, Sharp A: Quantitative image analysis of macular drusen from fundus photographs and scanning laser ophthalmoscope images. Eye 1995;9:48–55.
46.
Shin DS, Javornik NB, Berger JW: Computer-assisted, interactive fundus image processing for macular drusen quantitation. Ophthalmology 1999;106:1119–1125.
47.
Bartlett H, Eperjesi F: Use of fundus imaging in quantification of age-related macular change. Surv Ophthalmol 2007;52:655–671.
48.
Smith RT, Chan JK, Nagasaki T, Ahmad UF, Barbazetto I, Sparrow J, Figueroa M, Merriam J: Automated detection of macular drusen using geometric background leveling and threshold selection. Arch Ophthalmol 2005;123:200–206.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.